Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 4,286 | 3,826 | 2,145 | 4,395 | 4,066 |
| Operating Income | -4,286 | -3,826 | -2,145 | -4,395 | -4,066 |
| Other Income | 419 | 445 | -119 | -98 | -55 |
| Pre-tax Income | -3,868 | -3,381 | -2,265 | -4,492 | -4,122 |
| Net Income Continuous | -3,868 | -3,381 | -2,265 | -4,492 | -4,122 |
| Net Income | $-3,868 | $-3,381 | $-2,265 | $-4,492 | $-4,122 |
| EPS Basic Total Ops | -0.36 | -0.31 | -0.21 | -0.41 | -0.38 |
| EPS Basic Continuous Ops | -0.36 | -0.31 | -0.21 | -0.41 | -0.38 |
| EPS Diluted Total Ops | -0.36 | -0.31 | -0.21 | -0.41 | -0.38 |
| EPS Diluted Continuous Ops | -0.36 | -0.31 | -0.21 | -0.41 | -0.38 |
| EBITDA(a) | $-4,343 | $-3,829 | $-2,123 | $-4,376 | $-4,013 |